• 14 2014 July

    Using Data to Improve Future Cancer Treatments

    A new initiative called CancerLinQ will collect and analyze massive amounts of data to provide real-time quality feedback and clinical treatment support to oncologists through analytic tools. The White House has described the initiative as, “A groundbreaking health information technology (HIT) initiative to achieve higher quality, higher value cancer care

    ( Read More )
    Big data

    A new initiative called CancerLinQ will collect and analyze massive amounts of data to provide real-time quality feedback and clinical treatment support to oncologists through analytic tools. The White House has described the initiative as, “A groundbreaking health information technology (HIT) initiative to achieve higher quality, higher value cancer care

    read more →
  • 02 2014 July

    Massachusetts Law Allows Substitution of Biosimilars

    Massachusetts Governor Deval Patrick signed a bill which will allow substitution of interchangeable biosimilars. Though FDA currently oversees approval of biosimilar medicines, state law determines whether one product may be substituted in place of a doctor’s prescription. Full story.

    ( Read More )
    Deval Patrick

    Massachusetts Governor Deval Patrick signed a bill which will allow substitution of interchangeable biosimilars. Though FDA currently oversees approval of biosimilar medicines, state law determines whether one product may be substituted in place of a doctor’s prescription. Full story.

    read more →
  • 25 2014 June

    Exploding Big Myths About the Cost of Innovative Therapies

    American health spending is growing at its fastest rate in more than three decades, according to the federal government’s Bureau of Economic Analysis. For that, say many doctors and insurers, the cost of innovative drugs is to blame. But this single-minded focus on the price of cutting-edge medicines ignores the

    ( Read More )
    how-much-does-seo-cost

    American health spending is growing at its fastest rate in more than three decades, according to the federal government’s Bureau of Economic Analysis. For that, say many doctors and insurers, the cost of innovative drugs is to blame. But this single-minded focus on the price of cutting-edge medicines ignores the

    read more →
  • 24 2014 June

    Patient Needs Charity to Pay for Treatment Insurance Didn’t Cover

    “If it’s going to get me the medicine, I’ll put my hand out there with a tin cup,” said Stuart Rose, a hepatitis C patient in New York City. His insurance would pay only $4,000 a year for medications, but Rose was able to get assistance from charitable organizations. Full story.

    ( Read More )
    Beggar

    “If it’s going to get me the medicine, I’ll put my hand out there with a tin cup,” said Stuart Rose, a hepatitis C patient in New York City. His insurance would pay only $4,000 a year for medications, but Rose was able to get assistance from charitable organizations. Full story.

    read more →
  • 18 2014 June

    Swallowing a Computer with Your Pill May Someday Be Possible

    Tiny computers the size of a poppy seed capable of recording how your body responded to the drug have been approved by the Food and Drug Administration. Proteus, the company that makes them, hopes that it will become a part of regular prescribing. Full story.  

    ( Read More )
    Computer

    Tiny computers the size of a poppy seed capable of recording how your body responded to the drug have been approved by the Food and Drug Administration. Proteus, the company that makes them, hopes that it will become a part of regular prescribing. Full story.  

    read more →